Global Oral Insulin Therapies Market

Report ID : 1102 | Published : 2021-07-26 | Pages: 140 | Format: PDF/EXCEL

In people with type 1 diabetes, the pancreas does not make insulin — a hormone that helps glucose get into your cells to give them energy — which is why they take insulin. In Type 2 diabetes people, the body does not make or use insulin well, and so insulin therapy may be needed. Daily insulin shots for the management of diabetes could become a thing of the past, and insulin pills now are another option for diabetes patients. Diabetes ranks among the fast-growing chronic diseases in the United States. The prevailing cases of diabetes in the US are largely due to rising obesity levels, which is mainly due to their sedentary lifestyles, physical inactivities, unhealthy eating habits, and an increasingly aging population.
The diabetes drugs industry held the largest market share in the North American pharmaceutical sector due to the increasing prevalence of diabetes in this region and the presence of a high-quality health care system, which are the most influencing factors driving the market for diabetes drugs. It has proved that one in ten people in the country has diabetes, and it is expected to take the situation to one in three by 2050 by the rise in trends. The research and development are growing year on year in the insulin segments where researchers are trying to bring out the best molecule for patients use, suppressing the maximum side effects and increasing its efficiency. Better accessibility to treatment therapies and the presence of favorable reimbursement programs will result in a high turnout of patients opting for diabetes treatment. This will, in turn, fuel the growth of the US insulin market size during the next few years. Based on nanotechnology, innumerable research efforts are being made to develop pH-sensitive hydrogels, a three-dimensional network polymer structure that resembles those of the body tissues or cells that will encapsulate insulin in its cage and release the insulin through swelling and de-swelling mechanisms into the intestine.


The market research analysis presents a detailed segmentation of the oral insulin market by drug class (intermediate-acting, fast-acting, and long-acting), by the application (type 1 and type 2 diabetes). Type 2 diabetes is the largest segment of the global oral insulin market in terms of application. Based on regions, currently, urban areas consist of most of the diabetes patients as compared to rural areas. Based on gender, presently, females are accounting for the majority of the total diabetes patients. In terms of age groups, the age group 40-59 currently accounts for the majority of the total diabetes patients, followed by the age group 60-79 and 20-39 in the US.
Several pharmaceutical companies are now coming up with drugs that will use different therapeutic approaches to treat diabetes, besides developing new insulin-based products. For instance, Diabetes is a cell therapy-based product that secretes insulin on detecting elevated glucose levels. Recently, the increase in research activities for novel products will aid in the growth of the insulin market size in the US during the forecast period. Insulin Tregopil is the first oral insulin, which is under development by Biocon India. Zynquista (sotagliflozin) would be the first oral antidiabetic drug that has been approved in the U.S. SAR341402, the biosimilar version of Insulin Aspart, is under clinical trials studies by Sanofi.
Some of the few key players involved in the global oral insulin market include Abbott Laboratories, GlySens Incorporated, Echo Therapeutics Inc., Sanofi, Medtronic Plc, Novo Nordisk, Hoffmann-La Roche Ltd., MannKind Corporation, Dexcom Inc., and Senseonics Holding Inc.

  • Abbvie
  • GlySens Incorp
  • Echo Therapeutics
  • Medtronic
  • Sanofi
  • Novo Nordisk
  • Hoffmann-La Roche
  • MannKind Corp
  • Dexcom

Global Oral Insulin Therapy Market Segmentation

Global Oral Insulin Therapy Market Outlook (Revenue, US$ Mn, 2019 – 2030) based on Drug Class

  • Fast-acting
  • Intermediate-acting
  • Long-acting

Global Oral Insulin Therapy Market Outlook (Revenue, US$ Mn, 2019 – 2030) based on Application

  • Type 1 diabetes
  • Type 2 diabetes

Global Oral Insulin Therapy Market Outlook (Revenue, US$ Mn, 2019 – 2030) based on Gender

  • Female
  • Male

Global Oral Insulin Therapy Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients